ADAMTS9 and neuroblastoma: In addition, neuroblastoma samples with high ADAMTS9-AS2 expression showed higher differentiation compared with neuroblastoma samples with low ADAMTS9-AS2 expression (stratified based on median expression of ADAMTS9-AS2 in 121 neuroblastoma samples, Supplemental Table 2, P = 0.016).